共 26 条
[1]
Intravascular modalitiesfor detection of vulnerable plaque:current status. Macneill BD,Lowe HC,Takano M,et al. Arteriosclerosis Thrombosis and Vascular Biology . 2003
[2]
Accuracy of in vivo coronaryplaque morphology assessment:a validation study of in vivo virtualhistology compared with in vitro histopathology. Nasu K,Tsuchikane E,Katoh O,et al. Journal of the American College of Cardiology . 2006
[3]
Immunohistochemical analysis of hepatocyte growth factor in human coronary atherectomy specimens: comparison with transforming growth factor beta isoforms[J] . H. Ueda,Michinori Imazu,Yasuhiko Hayashi,Koichi Ono,Wataru Yasui,Michio Yamakido.  Virchows Archiv . 1997 (5)
[4]
Dyslipidemia and the vulnerable plaque
[J].
PROGRESS IN CARDIOVASCULAR DISEASES,
2002, 44 (06)
:415-428
Farmer, JA
;
Gotto, AM
.
[5]
Detection of fibrous cap in atherosclerotic plaque by intravascular Ultrasound by use of color mapping of angle-dependent echo-intensity variation. Hiro T,Fujji T,Yasumoto K,et al. Circulation . 2001
[6]
Increased secretion of tissue inhibitors of metal loproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metal loproteinases activity. Zaltsman AB. ArteriosclerThomb Vasc Biol . 1999
[7]
Detection oflipid pool,thin fibrous cap,and inflammatory cells in human aorticatherosclerotic plaques by near-infrared spectroscopy. Moreno PR,Lodder RA,Purushothaman KR,et al. Circulation . 2002
[8]
Production of hepatocyte growth factor during acute myocardial infarction. Zhu Y,Hojo Y,Ikeda U,et al. Heart . 2000
[9]
Dyslipidemia and vulnerable plaque. Farmer JA,Gotto AM Jr. Progress in Cardiovascular Diseases . 2002
[10]
Joint effects of C-reactive protein and other risk factors on acute coronary events. Kervinen H,Palosuo T,Manninen V,et al. American Heart Journal . 2001